Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Am J Kidney Dis. 2015 Mar 29;66(2):313–321. doi: 10.1053/j.ajkd.2015.02.325

Table 1.

Baseline Characteristics According to Adiponectin Tertiles in Maintenance Hemodialysis Patients.

Tertile 1 Tertile 2 Tertile 3 p-value1
No. of patients 32.9% (165) 33.1% (166) 33.9% (170) N/A
Adiponectin range (µg/ml) 0–16.1 >16.1–<30.1 >30.1–100 N/A
Age (y) 52.8 ± 14.5 56.6 ± 15.6 56.0 ± 14.6 0.6
Dialysis vintage (y) 2.9 (1.2, 5.3) 3.6 (1.5, 7.3) 3.9 (1.9, 7.1) 0.007
Female sex 34.6% (57) 48.2% (80) 47.7% (81) 0.02
Black race 45.5% (75) 36.1% (60) 38.2% (65) 0.2
Hispanic ethnicity 38.2% (63) 48.8% (81) 48.8% (83) 0.08
Diabetes 46.1% (76) 48.8% (81) 46.5% (79) 0.9
AVF/AVG 50.9% (84) 57.2% (95) 46.5% (79) 0.1
Smoking 35.2% (58) 36.8% (61) 36.5% (62) >0.9
Laboratory Tests
    Serum albumin (g/dl) 4.1 (3.9, 4.3) 4.0 (3.7, 4.2) 4.0 (3.7, 4.2) 0.06
    Creatinine (mg/dl) 9.9 (8.0, 12.3) 8.9 (7.2, 11.5) 9.3 (7.6, 11.0) 0.05
    Calcium2 (mg/dl) 9.1 (8.7, 9.7) 9.1 (8.7, 9.5) 9.2 (8.8, 9.6) 0.5
    Phosphorus (mg/dl) 4.8 (4.2, 6.1) 4.9 (4.0, 5.7) 4.9 (4.1, 6.1) 0.7
    PTH (pg/ml) 369 (203, 557) 346 (226, 549) 352 (250, 575) 0.8
    Hemoglobin (g/dl) 10.0 (10.6, 11.2) 10.8 (10.2, 11.3) 10.7 (10.1, 11.3) 0.4
    Platelet count (×109/L) 229 (191, 271) 226 (172, 275) 198 (156, 234) <0.001
    MPV (fL) 9.5 (9.0, 10.3) 9.8 (9.1, 10.6) 9.9 (9.1, 10.8) 0.2
    WBC count (×109/L) 7.0 (5.8, 8.4) 6.6 (5.5, 8.3) 5.9 (4.5, 7.2) <0.001
    TIBC (mcg/dl) 224 (207, 251) 221 (188, 253) 213 (193, 242) 0.08
    Ferritin (ng/ml) 676 (422, 899) 693 (416, 928) 684 (463, 907) 0.8
    nPCR (g/kg/day) 1.0 (0.8, 1.2) 1.0 (0.9, 1.2) 1.0 (0.8, 1.2) 0.4
    Glucose (mg/dl) 135 (97, 199) 142 (102, 196) 128 (88, 189) 0.8
    Hemoglobin A1c (%) 6.2 (5.7, 7.0) 6.2 (5.5, 7.2) 6.0 (5.5, 7.3) 0.8
    Total cholesterol (mg/dl) 146 (126, 166) 128 (112, 170) 144 (130, 177) 0.3
    HDL cholesterol (mg/dl) 34 (30, 42) 39 (30, 49) 45 (38, 56) 0.003
    LDL cholesterol (mg/dl) 76 (59, 91) 61 (47, 74) 66 (53, 104) 0.1
    Triglycerides (mg/dl) 164 (111, 265) 115 (93, 171) 101 (78, 141) <0.001
Body anthropometry
    BMI (kg/m2) 29.0 (25.5, 33.7) 26.1 (23.2, 30.3) 24.1 (21.9, 27.7) <0.001
    Waist circumference (cm) 101 (91, 115) 95 (84, 106) 88.5 (81.25, 100) <0.001
    Biceps SF (mm) 12.1 (8.0, 22.3) 11.1 (6.7, 19.7) 10.3 (5.7, 17.0) 0.04
    Triceps SF (mm) 20.3 (12.7, 29.3) 19.2 (12.7, 27.3) 16.0 (9.0, 23.3) 0.007
    NIR interactance body fat (%) 30.3 (23.0, 39.0) 29.6 (23.3, 38.0) 23.4 (18.3, 34.4) <0.001
    MAC (mm) 325 (290, 360) 302 (275, 335) 285 (261, 317) <0.001
    MAMC (mm) 261 (228, 293) 235 (215, 268) 236 (212, 257) <0.001

Note: Categorical variables are given as number (percentage); continuous variables, as mean ± standard deviation or median [IQR]. Conversion factors for units: calcium in mg/dL to mmol/L, ×0.2495; cholesterol in mg/dL to mmol/L, ×0.02586; creatinine in mg/dL to umol/L, ×88.4; glucose in mg/dL to mmol/L, ×0.05551; fibrinogen in mg/dL to µmol/L, ×0.0294; phosphorus in mg/dL to mmol/L, ×0.3229; triglycerides in mg/dL to mmol/L, ×0.01129.

1

P-value calculated by analysis of variance, chi-square, or Kruskal-Wallis tests.

2

Calcium level corrected for serum albumin.

Abbreviations: AVF, arteriovenous fistula; AVG, arteriovenous graft; BMI, body mass index; PTH, parathyroid hormone; MAC, midarm circumference; MAMC, midarm muscle circumference; MPV, mean platelet volume; WBC, white blood cell; TIBC, total iron-binding capacity; nPCR, normalized protein catabolic rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; triglyceride; SF, skinfold; N/A, not applicable; NIR, near-infrared